Financial Reports Latest Updates Industry Maps Economic Calendar

Bioceres Crop Solutions Corp. (BIOX) Annual Reports

Q: Where can I read Bioceres Crop Solutions Corp. (BIOX) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Bioceres Crop Solutions Corp. is listed on Nasdaq, classified by the SEC under Agricultural Chemicals (SIC 2870). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 06/30
SEC CIK： 1769484 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2025-12-31)
	Current	Prior year	YoY
Revenue	$73.7M	$106.8M	-31.0%
Operating income	$7.5M	$7.9M	-5.0%
Net income	$-182.5M	$143,535	-127225.5%
EPS (diluted)	$-2.88	$0.00	-125473.9%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 73.7 mn Net income -182 mn

Periods follow the company’s fiscal year (Apple ends in September, Walmart in January), so they differ from calendar quarters.

Show table：Income statement

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	41.0	46.9	133	62.5	68.3	62.3	73.8	48.0	117	92.3	68.2	102	127	94.5	93.0	105	116	140	84.0	124	92.6	107	59.6	74.4	77.4	73.7
Gross profit	10.6	—	56.5	44.4	29.2	45.9	33.6	42.9	48.0	66.3	23.7	36.4	51.7	33.5	56.4	38.7	45.0	51.5	42.6	47.4	37.5	45.1	23.9	25.2	36.3	26.6
Operating income	0.21	-1.00	15.7	19.0	4.91	19.6	13.4	11.5	18.5	17.7	2.15	9.98	17.0	2.22	29.9	5.11	5.29	16.8	13.2	9.48	2.37	7.92	0.93	-13.5	7.21	7.52
Net income	-5.87	-5.91	-11.0	6.85	-22.6	11.3	-0.91	0.65	-0.55	3.43	-6.49	-5.01	0.5	-8.16	28.1	-1.71	-4.59	0.11	9.26	-1.53	-6.37	0.14	-1.30	-47.9	-7.33	-182

Balance sheet

Quarterly · In mn (USD)

Total assets 560 mn Total liabilities 454 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	87.8	85.3	—	98.2	129	165	186	211	272	—	298	—	451	421	397	395	392	407	409	377	383	338	308	283	294
Total assets	—	240	197	—	242	262	298	346	395	470	—	518	—	873	847	818	820	820	836	851	827	835	798	764	735	560
Current liabilities	—	69.4	119	—	116	140	131	165	168	180	—	223	—	331	303	299	312	317	333	330	296	289	332	338	300	329
Total liabilities	—	163	164	—	180	201	237	268	304	358	—	360	—	566	513	488	487	484	488	501	481	489	453	468	447	454
Equity	83.7	35.8	13.7	54.8	47.3	46.7	46.2	61.3	67.7	84.2	117	127	315	273	301	299	299	301	313	314	309	310	308	265	259	76.4

Cash flow

Quarterly · In mn (USD)

Operating 17.4 mn Investing -2.80 mn Financing -18.0 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-1.22	9.55	18.4	-1.90	31.6	6.28	5.14	-23.6	17.4	-19.9	7.77	-5.42	-32.4	41.2	2.25	-8.49	14.7	21.1	-17.4	23.3	5.16	-5.36	23.3	26.8	14.4	17.4
Investing	-41.9	-10.1	-8.22	-1.55	-1.71	-1.59	-20.6	1.56	-9.87	3.97	0.32	-1.38	3.03	-22.3	-3.26	-3.24	-8.69	-18.4	-1.37	-0.3	0.27	-5.39	-2.50	1.49	-1.26	-2.80
Financing	44.0	1.17	-10.5	5.21	-32.1	1.29	32.3	13.8	-6.42	17.8	-4.54	1.59	40.2	0.12	-10.7	3.32	-27.0	0.7	10.9	5.32	-18.8	6.49	-12.7	-25.7	-28.7	-18.0
Cash at period end	—	1.68	2.22	—	3.45	10.6	27.2	19.1	36.0	36.4	—	33.5	—	68.5	57.7	48.1	28.4	24.4	16.4	44.5	32.3	29.2	38.5	32.7	15.5	11.1

Profitability

Quarterly · %

Gross margin 36.2% Operating margin 10.2% Net margin -247.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	25.8%	—	42.3%	71.1%	42.8%	73.8%	45.5%	89.4%	41.1%	71.9%	34.7%	35.9%	40.7%	35.5%	60.6%	36.8%	38.7%	36.7%	50.7%	38.1%	40.5%	42.3%	40.0%	33.9%	46.9%	36.2%
Operating margin	0.5%	-2.1%	11.8%	30.4%	7.2%	31.4%	18.1%	24.0%	15.8%	19.2%	3.1%	9.8%	13.4%	2.4%	32.1%	4.9%	4.6%	12.0%	15.7%	7.6%	2.6%	7.4%	1.6%	-18.1%	9.3%	10.2%
Net margin	-14.3%	-12.6%	-8.3%	11.0%	-33.1%	18.2%	-1.2%	1.4%	-0.5%	3.7%	-9.5%	-4.9%	0.4%	-8.6%	30.3%	-1.6%	-4.0%	0.1%	11.0%	-1.2%	-6.9%	0.1%	-2.2%	-64.4%	-9.5%	-247.7%

Returns & leverage

Quarterly · %

ROE -123.8% ROA -34.3% Debt ratio 81.0%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-29.1%	-49.9%	-37.5%	-17.8%	-19.9%	18.3%	4.0%	-3.6%	-9.1%	-4.0%	-10.7%	7.4%	8.8%	4.5%	7.7%	1.0%	1.1%	0.5%	0.5%	-2.9%	-19.1%	-19.9%	-123.8%
ROA	—	—	—	—	-13.5%	-6.2%	-2.2%	-3.3%	3.3%	0.7%	—	-2.0%	—	-2.9%	1.8%	2.8%	1.7%	2.6%	0.4%	0.4%	0.2%	0.2%	-1.1%	-6.9%	-7.2%	-34.3%
Debt ratio	—	67.8%	83.2%	—	74.4%	76.7%	79.6%	77.5%	77.1%	76.3%	—	69.5%	—	64.9%	60.5%	59.6%	59.4%	59.1%	58.3%	58.9%	58.2%	58.5%	56.8%	61.3%	60.8%	81.0%

EPS

Quarterly · US$

EPS US$-2.88

Show table：EPS

Item	2016Q4	2018Q1	2018Q4	2019Q2	2019Q4	2020Q2	2020Q4	2021Q2	2021Q4	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	-0.39	—	-0.60	0.31	-0.03	0.02	-0.01	0.08	-0.16	-0.12	0.01	-0.13	0.45	-0.03	-0.07	0.00	0.14	-0.02	-0.10	0.00	-0.02	-0.76	-0.12	-2.88

Revenue & profit

Year-to-date · In mn (USD)

Revenue 151 mn Net income -190 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 560 mn Total liabilities 454 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 31.8 mn Investing -4.07 mn Financing -46.7 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 41.7% Operating margin 9.8% Net margin -125.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -123.8% ROA -34.3% Debt ratio 81.0%

EPS

Year-to-date · US$

EPS US$-3.00

Revenue & profit

Annual · In mn (USD)

Revenue 333 mn Net income -55.4 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2023	2024	2025
Revenue	419	465	333
Gross profit	180	187	132
Operating income	54.2	44.8	-2.24
Net income	18.8	3.24	-55.4

Balance sheet

Annual · In mn (USD)

Total assets 764 mn Total liabilities 468 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2023	2024	2025
Current assets	397	409	308
Total assets	818	851	764
Current liabilities	299	330	338
Total liabilities	488	501	468
Equity	299	314	265

Cash flow

Annual · In mn (USD)

Operating 49.9 mn Investing -6.13 mn Financing -50.7 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2023	2024	2025
Operating	2.59	41.7	49.9
Investing	-25.7	-28.7	-6.13
Financing	33.0	-10.1	-50.7
Cash at period end	48.1	44.5	32.7

Profitability

Annual · %

Gross margin 39.5% Operating margin -0.7% Net margin -16.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2023	2024	2025
Gross margin	43.0%	40.1%	39.5%
Operating margin	12.9%	9.6%	-0.7%
Net margin	4.5%	0.7%	-16.6%

Returns & leverage

Annual · %

ROE -19.1% ROA -6.9% Debt ratio 61.3%

Show table：Returns & leverage

Item	2023	2024	2025
ROE	6.3%	1.1%	-19.1%
ROA	2.3%	0.4%	-6.9%
Debt ratio	59.6%	58.9%	61.3%

EPS

Annual · US$

EPS US$-0.88

Show table：EPS

Item	2023	2024	2025
EPS（US$）	0.29	0.05	-0.88

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	20-F
2025	Open full text →
2024	Open full text →
2023	Open full text →

20-F: annual report of a foreign private issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Bioceres Crop Solutions Corp. (BIOX) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.